atomoxetine

Poland

Drugs containing this active substance

  • ATOFAB

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults. It should be used as part of a comprehensive treatment program, which also includes non-pharmacological methods, such as behavioral therapy.

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 10 mg

    ATC: N06BA09

    Manufacturer: G.L. Pharma GmbH

  • ATOFAB

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults. It should be used as part of a full treatment program, which also includes non-pharmacological methods, such as behavioral therapy.

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 18 mg

    ATC: N06BA09

    Manufacturer: G.L. Pharma GmbH

  • ATOFAB

    The medicinal product is used to treat attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults. It should be used as part of a full treatment program, which also includes non-pharmacological methods, such as behavioral therapy.

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 25 mg

    ATC: N06BA09

    Manufacturer: G.L. Pharma GmbH

  • ATOFAB

    The medicine is used to treat attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults. It should be used as part of a full treatment program, which also includes non-pharmacological methods, such as behavioral therapy.

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 40 mg

    ATC: N06BA09

    Manufacturer: G.L. Pharma GmbH

  • AUROXETINE

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults (if symptoms are bothersome and have been present since childhood).

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 40 mg

    ATC: N06BA09

    Manufacturer: Aurobindo Pharma B.V.

  • AUROXETYN

    The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults. It is used as part of a full treatment program, which also includes non-pharmacological methods, such as behavioral therapy.

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 40 mg

    ATC: N06BA09

    Manufacturer: Aurobindo Pharma B.V.

  • AUROXETYN

    Auroxetyn is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults. In adults, it is used when symptoms are very troublesome and have been present since childhood.

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 25 mg

    ATC: N06BA09

    Manufacturer: Aurobindo Pharma B.V.

  • AUROXETYN

    The medicine is used to treat attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults. In adults, it is used when symptoms are very bothersome and were present during childhood.

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 25 mg

    ATC: N06BA09

    Manufacturer: Aurobindo Pharma B.V.

  • KAMAPTIN

    The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults.

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 10 mg

    ATC: N06BA09

    Manufacturer: Fairmed Healthcare GmbH Synoptis Industrial Sp. z o.o.

  • KAMAPTIN

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults.

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 18 mg

    ATC: N06BA09

    Manufacturer: Fairmed Healthcare GmbH Synoptis Industrial Sp. z o.o.

  • KAMAPTIN

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults.

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 25 mg

    ATC: N06BA09

    Manufacturer: Fairmed Healthcare GmbH Synoptis Industrial Sp. z o.o.

  • KAMAPTIN

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults (in adults, when symptoms are very troublesome and were present in childhood).

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 40 mg

    ATC: N06BA09

    Manufacturer: Fairmed Healthcare GmbH Synoptis Industrial Sp. z o.o.

  • KAMAPTIN

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults.

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 60 mg

    ATC: N06BA09

    Manufacturer: Fairmed Healthcare GmbH Synoptis Industrial Sp. z o.o.

  • KAMAPTIN

    Kamaptin is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults.

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 80 mg

    ATC: N06BA09

    Manufacturer: Fairmed Healthcare GmbH Synoptis Industrial Sp. z o.o.

  • KAMAPTIN

    The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults.

    Form: capsules, hard

    Active substance Dosage
    atomoxetine 100 mg

    ATC: N06BA09

    Manufacturer: Fairmed Healthcare GmbH Synoptis Industrial Sp. z o.o.